2 documents found, page 1 of 1
Differences in Nevirapine Biotransformation as a Factor for its Sex-Dependent D...
Marinho, AT; Rodrigues, PM; Caixas, U; Antunes, A; Branco, T; Harjivan, S; Marques, MM; Monteiro, EC; Pereira, SAOBJECTIVES: Nevirapine is widely used for the treatment of HIV-1 infection; however, its chronic use has been associated with severe liver and skin toxicity. Women are at increased risk for these toxic events, but the reasons for the sex-related differences are unclear. Disparities in the biotransformation of nevirapine and the generation of toxic metabolites between men and women might be the underlying cause....
Effect of Efavirenz on High-Density Lipoprotein Antioxidant Properties in HIV-I...
Pereira, SA; Batuca, JR; Caixas, U; Branco, T; Delgado-Alves, J; Germano, I; Lampreia, F; Monteiro, ECWHAT IS ALREADY KNOWN ABOUT THIS SUBJECT: * In previous work, we showed a long-term and concentration-dependent beneficial effect of the non-nucleoside reverse transcriptase inhibitor efavirenz (EFV) on high-density lipoproteins (HDL) in human immunodeficiency virus (HIV)-infected patients. * Furthermore, it has been suggested that instead of the current practice of only measuring HDL-chelesterol values, the ev...